Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
4 passages
REFERENCES Baddour LM, Wilson WR, Bayer AS, et al, “Infective Endocarditis. Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association - Executive Summary: Endorsed by the Infectious Diseases Society of America ,” Circulation , 2005, 111(23):3167-184. [PubMed 15956145 ] Boguniewicz M and Leung DY, “Hypersensitivity Reactions to Antibiotics Commonly Used in Children,” Pediatr Infect Dis J , 1995, 14(3):221-31. [PubMed 7761188 ] Bradley JS, Byington CL, Shah SS, et al. “The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America”, Clin Infect Dis , 2011, 53(7):e25-76. [PubMed 21880587 ] Bratzler DW, Dellinger EP, Olsen KM, et al, “Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery,” Am J Health Syst Pharm , 2013, 70(3):195-283. [PubMed 23327981 ] Brown RD and Campoli-Richards DM, “Antimicrobial Therapy in Neonates, Infants, and Children,” Clin Pharmacokinet , 1989, 17(Suppl 1):105-15. [PubMed 2692934 ] Centers for Disease Control and Prevention (CDC), "Prevention of Perinatal Group B Streptococcal Disease, Revised Guidelines from CDC, 2010," MMWR Recomm Rep , 2010, 59(RR-10):1-32. [PubMed 21088663 ] Chow MS, Quintiliani R, and Nightingale CH, " In Vivo Inactivation of Tobramycin by Ticarcillin. A Case Report," JAMA , 1982, 247(5):658-9. [PubMed 6798229 ] Dajani AS, Taubert KA, Wilson W, et al, “Prevention of Bacterial Endocarditis Recommendations by the American Heart Association,” JAMA , 1997, 277(22):1794-801. [PubMed 9178793 ] Daly JS, Dodge RA, Glew RH, et al, "Effect of Time and Temperature on Inactivation of Aminoglycosides by Ampicillin at Neonatal Dosages," J Perinatol , 1997, 17(1):42-5. [PubMed 9069064 ] Donowitz GR and Mandell GL, “Beta-Lactam Antibiotics,” N Engl J Med , 1988, 318(7):419-26 and 318(8):490-500. [PubMed 3277054 ]
Dajani AS, Taubert KA, Wilson W, et al, “Prevention of Bacterial Endocarditis Recommendations by the American Heart Association,” JAMA , 1997, 277(22):1794-801. [PubMed 9178793 ] Daly JS, Dodge RA, Glew RH, et al, "Effect of Time and Temperature on Inactivation of Aminoglycosides by Ampicillin at Neonatal Dosages," J Perinatol , 1997, 17(1):42-5. [PubMed 9069064 ] Donowitz GR and Mandell GL, “Beta-Lactam Antibiotics,” N Engl J Med , 1988, 318(7):419-26 and 318(8):490-500. [PubMed 3277054 ] Dowell JA, Korth-Bradley J, Milisci M, et al, "Evaluating Possible Pharmacokinetic Interactions Between Tobramycin, Piperacillin, and a Combination of Piperacillin and Tazobactam in Patients With Various Degrees of Renal Impairment," J Clin Pharmacol , 2001, 41:979-86. [PubMed 11549103 ] Farchione LA, "Inactivation of Aminoglycosides by Penicillins," J Antimicrob Chemother , 1982, 8(Suppl A):27-36. Fuchs PC, Stickel S, Anderson PH, et al, " In Vitro Inactivation of Aminoglycosides by Sulbactam, Other Beta-Lactams, and Sulbactam-Beta-Lactam Combinations," Antimicrob Agents Chemother , 1991, 35(1):182-4. [PubMed 2014975 ] Halstenson CE, Wong MO, Herman CS, et al, "Effect of Concomitant Administration of Piperacillin on the Dispositions on Isepamicin and Gentamicin in Patients With End-Stage Renal Disease," Antimicrob Agents Chemother , 1992, 36(9):1832-36. [PubMed 1416875 ] Heintz BH, Matzke GR, Dager WE, “Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis,” Pharmacotherapy , 2009, 29(5):562-77. [PubMed 19397464 ] Hitt CM, Patel KB, Nicolau DP, et al, "Influence of Piperacillin-Tazobactam on Pharmacokinetics of Gentamicin Given Once Daily," Am J Health Syst Pharm , 1997, 54(23):2704-8. [PubMed 9408514 ] Konishi H, Goto M, Nakamoto Y, et al, "Tobramycin Inactivation by Carbenicillin, Ticarcillin, and Piperacillin," Antimicrob Agents Chemother , 1983, 23(5):653-57. [PubMed 6223576 ] Lau A, Lee M, Flascha S, et al, "Effect of Piperacillin on Tobramycin Pharmacokinetics in Patients With Normal Renal Function," Antimicrob Agents Chemother , 1983, 24(4):533-37. [PubMed 6651279 ]
Konishi H, Goto M, Nakamoto Y, et al, "Tobramycin Inactivation by Carbenicillin, Ticarcillin, and Piperacillin," Antimicrob Agents Chemother , 1983, 23(5):653-57. [PubMed 6223576 ] Lau A, Lee M, Flascha S, et al, "Effect of Piperacillin on Tobramycin Pharmacokinetics in Patients With Normal Renal Function," Antimicrob Agents Chemother , 1983, 24(4):533-37. [PubMed 6651279 ] Osmon DR, Berbari EF, Berendt AR, et al, “Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guideline by the Infectious Diseases Society of America,” Clin Infect Dis , 2013, 56(1):e1-25. [PubMed 23223583 ] Russoe ME and Atkins-Thor E, "Gentamicin and Ticarcillin in Subjects With End-Stage Renal Disease. Comparison of Two Assay Methods and Evaluation of Inactivation Rate," Clin Nephrol , 1981, 15(4):175-80. [PubMed 7237864 ] Tenenbein M, Cohen S, and Sitar DS, “Whole Bowel Irrigation as a Decontamination Procedure After Acute Drug Overdose,” Arch Intern Med , 1987, 147(5):905-7. [PubMed 3579442 ] Thompson MIB, Russo ME, Saxon BJ, et al, "Gentamicin Inactivation by Piperacillin or Carbenicillin in Patients With End-Stage Renal Disease," Antimicrob Agents Chemother , 1982, 21(2):268-73. [PubMed 6462107 ] Triggs EJ, Johnson JM, and Learoyd B, “Absorption and Disposition of Ampicillin in the Elderly,” Eur J Clin Pharmacol , 1980, 18(2):195-8. [PubMed 7428803 ] Tunkel AR, Hartman BJ, Kaplan SL, et al, “Practice Guidelines for the Management of Bacterial Meningitis,” Clin Infect Dis , 2004, 39(9):1267-84. [PubMed 15494903 ] Viollier AF, Standiford HC, Drusano GL, et al, "Comparative Pharmacokinetics and Serum Bactericidal Activity of Mezlocillin, Ticarcillin and Piperacillin, With and Without Gentamicin," J Antimicrob Chemother , 1985, 15(5):597-606. [PubMed 4008387 ] Walterspiel JN, Feldman S, Van R, et al, "Comparative Inactivation of Isepamicin, Amikacin, and Gentamicin by Nine Beta-Lactams and Two Beta-Lactamase Inhibitors, Cilastatin and Heparin," Antimicrob Agents Chemother , 1991, 35(9):1875-8. [PubMed 1952861 ]
Viollier AF, Standiford HC, Drusano GL, et al, "Comparative Pharmacokinetics and Serum Bactericidal Activity of Mezlocillin, Ticarcillin and Piperacillin, With and Without Gentamicin," J Antimicrob Chemother , 1985, 15(5):597-606. [PubMed 4008387 ] Walterspiel JN, Feldman S, Van R, et al, "Comparative Inactivation of Isepamicin, Amikacin, and Gentamicin by Nine Beta-Lactams and Two Beta-Lactamase Inhibitors, Cilastatin and Heparin," Antimicrob Agents Chemother , 1991, 35(9):1875-8. [PubMed 1952861 ] Wilson W, Taubert KA, Gewitz M, et al, “Prevention of Infective Endocarditis. Guidelines From the American Heart Association. A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group,” Circulation , 2007, 115. [PubMed 17446442 ] Wright AJ, “The Penicillins,” Mayo Clin Proc , 1999, 74(3):290-307. [PubMed 10090000 ] Topic 8737 Version 46.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0603-89.32.226.102-5846377118-S244013.14]